Zhun Cao, PhD
Articles
January 16th 2012
Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression
Teresa B. Gibson, PhD Yonghua Jing, PhD Jill E. Bagalman, MSW Zhun Cao, PhD John A. Bates, PhD Tony Hebden, PhD Robert A. Forbes, PhD Jalpa A. Doshi, PhD
Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.
June 10th 2010
Jay M. Margolis, PharmD Zhun Cao, PhD Eberechukwu Onukwugha, PhD Robert J. Sanchez, MS Jose Alvir, DrPH Ashish V. Joshi, PhD C. Daniel Mullins, PhD
Prior authorization for pregabalin in commercial insurance plans accomplished the objective of lower pregabalin utilization; however, there was no significant decrease in disease-related healthcare costs.
Latest Updated Articles
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: October 14th 2024 | Updated: October 22nd 2024
Exploring the Kidney-CHAMP Study
Published: October 14th 2024 | Updated: October 22nd 2024
Takeaways from the UH CINEMA Program
Published: October 7th 2024 | Updated: October 22nd 2024
Care Coordination for High-Risk CRM Patients
Published: October 7th 2024 | Updated: October 22nd 2024
Addressing Gaps in CKD, T2D, and CVD Guidelines
